Engineered immune cells take on hard-to-treat blood cancers

NCT ID NCT03938987

First seen Feb 10, 2026 · Last updated Apr 23, 2026 · Updated 16 times

Summary

This study tests a treatment that uses a patient's own immune cells, modified in a lab to better attack cancer cells. It is for people with certain types of lymphoma or leukemia that have come back or not responded to other treatments. The goal is to see if the therapy is safe and how well it works at controlling the cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED NON-HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alberta Children's Hospital

    NOT_YET_RECRUITING

    Calgary, Alberta, T3B6A8, Canada

    Contact

  • Cross Cancer Institute

    RECRUITING

    Edmonton, Alberta, T6G1Z2, Canada

    Contact

  • Foothills Medical Centre

    NOT_YET_RECRUITING

    Calgary, Alberta, T2N2T9, Canada

    Contact

  • Stollery Children's Hospital

    NOT_YET_RECRUITING

    Edmonton, Alberta, T6G2B7, Canada

    Contact

  • Tom Baker Cancer Centre

    NOT_YET_RECRUITING

    Calgary, Alberta, T2N4N2, Canada

    Contact

  • University of Alberta Hospital

    RECRUITING

    Edmonton, Alberta, T6G2B7, Canada

    Contact

Conditions

Explore the condition pages connected to this study.